Estimation of population pharmacokinetics using the Gibbs sampler

[1]  James E. Bennett,et al.  The Bayesian modeling of covariates for population pharmacokinetic models , 1996 .

[2]  W. Gilks,et al.  Adaptive Rejection Metropolis Sampling Within Gibbs Sampling , 1995 .

[3]  B. Carlin,et al.  Bayesian Model Choice Via Markov Chain Monte Carlo Methods , 1995 .

[4]  A. Gelfand,et al.  Bayesian Model Choice: Asymptotics and Exact Calculations , 1994 .

[5]  Adrian F. M. Smith,et al.  Bayesian Analysis of Linear and Non‐Linear Population Models by Using the Gibbs Sampler , 1994 .

[6]  Jon Wakefield,et al.  An Expected Loss Approach to the Design of Dosage Regimens Via Sampling‐Based Methods , 1994 .

[7]  A. W. Kemp,et al.  Kendall's Advanced Theory of Statistics. , 1994 .

[8]  Leon Aarons.  The estimation of population pharmacokinetic parameters using an EM algorithm. , 1993, Computer methods and programs in biomedicine.

[9]  D. Spiegelhalter,et al.  Modelling Complexity: Applications of Gibbs Sampling in Medicine , 1993 .

[10]  Adrian F. M. Smith,et al.  Bayesian computation via the gibbs sampler and related markov chain monte carlo methods (with discus , 1993 .

[11]  J. Q. Smith,et al.  1. Bayesian Statistics 4 , 1993 .

[12]  Hong Chang,et al.  Model Determination Using Predictive Distributions with Implementation via Sampling-Based Methods , 1992 .

[13]  D. Rubin,et al.  Inference from Iterative Simulation Using Multiple Sequences , 1992 .

[14]  Marie Davidian,et al.  Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine , 1992, Journal of Pharmacokinetics and Biopharmaceutics.

[15]  Lewis B. Sheiner,et al.  Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects , 1992, Journal of Pharmacokinetics and Biopharmaceutics.

[16]  G. Casella,et al.  Explaining the Gibbs Sampler , 1992 .

[17]  Adrian F. M. Smith,et al.  Hierarchical Bayesian Analysis of Changepoint Problems , 1992 .

[18]  E. Vonesh,et al.  Mixed-effects nonlinear regression for unbalanced repeated measures. , 1992, Biometrics.

[19]  Adrian F. M. Smith,et al.  Efficient generation of random variates via the ratio-of-uniforms method , 1991 .

[20]  L. Wasserman,et al.  Bayesian analysis of outlier problems using the Gibbs sampler , 1991 .

[21]  A. Raftery,et al.  How Many Iterations in the Gibbs Sampler , 1991 .

[22]  D. Stanski,et al.  A three-step approach combining bayesian regression and NONMEM population analysis: Application to midazolam , 1991, Journal of Pharmacokinetics and Biopharmaceutics.

[23]  D. B. White,et al.  An evaluation of point and interval estimates in population pharmacokinetics using Nonmem analysis , 1991, Journal of Pharmacokinetics and Biopharmaceutics.

[24]  Adrian F. M. Smith,et al.  Bayesian Analysis of Constrained Parameter and Truncated Data Problems , 1991 .

[25]  D. Bates,et al.  Nonlinear mixed effects models for repeated measures data. , 1990, Biometrics.

[26]  Adrian F. M. Smith,et al.  Sampling-Based Approaches to Calculating Marginal Densities , 1990 .

[27]  J. N. R. Jeffers,et al.  Graphical Models in Applied Multivariate Statistics. , 1990 .

[28]  L Aarons,et al.  Population pharmacokinetics of tobramycin. , 1989, British journal of clinical pharmacology.

[29]  L. Joseph,et al.  Bayesian Statistics: An Introduction , 1989 .

[30]  P. J. Green,et al.  Density Estimation for Statistics and Data Analysis , 1987 .

[31]  A. Mallet.  A maximum likelihood estimation method for random coefficient regression models , 1986 .

[32]  A Racine-Poon,et al.  A Bayesian approach to nonlinear random effects models. , 1985, Biometrics.

[33]  J. Kasik,et al.  Postconceptional age and gentamicin elimination half-life. , 1985, The Journal of pediatrics.

[34]  A W Kelman,et al.  Estimation of gentamicin clearance and volume of distribution in neonates and young children. , 1984, British journal of clinical pharmacology.

[35]  Donald Geman,et al.  Stochastic Relaxation, Gibbs Distributions, and the Bayesian Restoration of Images , 1984, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[36]  B. Arant.  Estimating glomerular filtration rate in infants. , 1984, The Journal of pediatrics.

[37]  Philip Heidelberger,et al.  Simulation Run Length Control in the Presence of an Initial Transient , 1983, Oper. Res..

[38]  S. Weisberg,et al.  Residuals and Influence in Regression , 1982 .

[39]  I. Phillips.  AMINOGLYCOSIDES , 1982, The Lancet.

[40]  Lewis B. Sheiner,et al.  Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic data , 1980, Journal of Pharmacokinetics and Biopharmaceutics.

[41]  R. Cipolle,et al.  Kinetic model for gentamicin dosing with the use of individual patient parameters , 1977, Clinical pharmacology and therapeutics.

[42]  R. Sawchuk,et al.  Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: Gentamicin in burn patients , 1976, Journal of Pharmacokinetics and Biopharmaceutics.

[43]  David Lindley,et al.  Optimal Statistical Decisions , 1971 .

[44]  P. Odell,et al.  A Numerical Procedure to Generate a Sample Covariance Matrix , 1966 .

[45]  N. Metropolis,et al.  Equation of State Calculations by Fast Computing Machines , 1953, Resonance.

[46]  Brian D. Ripley,et al.  Stochastic Simulation , 2005 .

[47]  A W Kelman,et al.  Population pharmacokinetics of gentamicin in neonates. , 1988, Developmental pharmacology and therapeutics.

[48]  J F Boisvieux,et al.  Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model. , 1984, Drug metabolism reviews.

[49]  G. Kearns,et al.  Gentamicin disposition and effect on development of renal function in the very low birth weight infant. , 1984, Developmental pharmacology and therapeutics.

[50]  J. Besag.  Spatial Interaction and the Statistical Analysis of Lattice Systems , 1974 .

[51]  B. Carlin,et al.  Diagnostics: A Comparative Review , 2022 .

[52]  and as an in , 2022 .